Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
Operating Expenses | 2,164 | 2,374 | 1,878 | 1,296 | 1,486 |
Operating Income | -2,164 | -2,374 | -1,877 | -1,297 | -1,486 |
Interest Expense | 1 | 1 | 1 | 1 | 1 |
Other Income | 0 | 0 | -1 | 1 | 0 |
Pre-tax Income | -2,165 | -2,374 | -1,878 | -1,297 | -1,486 |
Net Income Continuous | -2,165 | -2,374 | -1,878 | -1,297 | -1,486 |
Net Income | $-2,165 | $-2,374 | $-1,878 | $-1,297 | $-1,486 |
EPS Basic Total Ops | -31.47 | -33.95 | -28.16 | -19.88 | -19.88 |
EPS Basic Continuous Ops | -31.11 | -34.12 | -27.08 | -18.63 | -21.36 |
EPS Diluted Total Ops | -31.47 | -33.95 | -28.16 | -19.88 | -19.88 |
EPS Diluted Continuous Ops | -31.11 | -34.12 | -27.08 | -18.63 | -21.36 |
EBITDA(a) | $-2,088 | $-2,306 | $-1,825 | $-1,239 | $-1,415 |